Detecting and Curing Cancer With Nanoparticles and Nanobiosensors

One of the ultimate goals of medical researchers is to develop a method of curing cancer that is pain free, fast and has no side effects. Developments in the nanotechnology fields of nanobiosensors and nanoparticles may be able to deliver upon this goal.

Current developments of nanobiosensors aim to identify the disease at the earliest stage possible, ideally at the level of a single cell or multiple cells of cancer. Nanoparticles could then be used to precisely deliver drugs to the tiny tumor, destroying it well before the patient develops even the smallest of symptoms.

Just released on the nanotechnology website AZoNano, is a comprehensive review of the latest progress in the use of nanoparticles and nano sized biosensors for cancer detection and treatment. The article by Priya Pathak, V. K. Katiyar and Shibashish Giri, researchers from the Indian Institute of Technology Roorkee, has been released as part of the open access journal, AZoJono.

The first part of the paper focuses on nanoparticles, their transport & cancer drug delivery. In the second part biosensors are discussed with reference to the development of nanobiosensors and their role in cancer care.

The article is available to view in full at https://www.azonano.com/Details.asp?ArticleID=1977

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.